MD&A · 2025
In this section3 topics
Overview of Operations
Overview of Operations
Management Discussion and Analysis: MD&A
Performance and Profitability
Profit and Loss Statement (Unit: Million Baht) | 2025 | 2024 | Change |
Revenues | |||
Medical service income | 1,794.99 | 1,746.79 | 2.8% |
Other income | 49.62 | 57.59 | -13.8% |
Total Revenues | 1,844.61 | 1,804.38 | 2.2% |
Expenses | |||
Cost of medical services | 1,427.34 | 1,432.85 | -0.4% |
Administrative expenses | 226.64 | 213.74 | 6.0% |
Total expenses | 1,653.98 | 1,646.59 | 0.4% |
Profit from operating activities | 190.63 | 157.79 | 20.8% |
Earnings Before Interest Tax Depreciation and Amortization (EBITDA) | 280.41 | 241.96 | 15.9% |
Earnings Before Interest Tax Depreciation and Amortization Margin (EBITDA Margin) | 15.2% | 13.4% | |
Finance costs | 0.19 | 0.13 | 46.1% |
Profit before income tax expenses | 190.44 | 157.66 | 20.8% |
Income tax expenses | 36.70 | 30.65 | 19.7% |
Profit for the year | 153.74 | 127.01 | 21.0% |
Basic earnings per share (Baht per share) | 1.03 | 0.85 | 21.0% |
Hospital Operating Revenue
The combined revenue of both hospitals in 2025 was 1,794.99 million Baht, an increase of 48.20 million Baht or 2.8% from 2024. The primary growth driver was an increase in outpatient department (OPD) revenue, bolstered by rising demand for non-communicable diseases (NCDs) services, such as hypertension, diabetes, and cardiovascular diseases. Furthermore, the company hosted the "Aikchol Health Fair" at Central Chonburi in November to enhance brand awareness and deliver premium healthcare experiences. The event received a positive response, leading to a significant uptick in health check-up volume. Conversely, inpatient department revenue experienced slight contraction. This was primarily due to the ongoing renovation of inpatient wards on the 4th and 5th floors. These renovations aim to modernize the facilities and improve long-term service capacity. Consequently, the hospital operated at limited capacity during this period, despite an underlying increase in patient demand.
Revenue from the Social Security scheme showed an upward trend, primarily driven by higher claims for high-intensity cases (AdjRW ≥ 2) and the increased in risk-adjusted capitation revenue. However, during the fourth quarter of 2024, the company recorded the reduction in the reimbursement rate for high-intensity cases (AdjRW ≥ 2) from the Social Security Office. This adjustment led to a decrease in revenue contribution from the Social Security scheme during the period. Looking ahead to 2025, the Social Security Office has announced a reversion to standard reimbursement rates. This policy shift is expected to normalize revenue recognition and support the recovery of Social Security income in the upcoming fiscal year.
Other Income
The other income in year 2025 totaled 49.62 million Baht, a decrease of 7.97 million Baht or -13.8% from last year. This decline was primarily attributed to lower interest income, resulting from a reduction in unrealized gain from mutual fund fixed income.
Cost of Medical Services
The total medical services costs and administrative expenses relating to both hospitals in 2025 including depreciation and amortization showed at 1,653.98 million Baht, an increase of 7.39 million Baht, 0.4% from the previous year.
The cost of medical care in 2025 is equal to 1,427.34 million Baht, a decrease of 5.51 million Baht or -0.4%. The primary factor contributing to cost efficiency was a reduction in medicine and medical supply costs compared to the previous year, driven by the company’s stringent cost-control measures. However, medical personnel expenses and staff remunerations increased in correlation with the growth in healthcare service revenue. Additionally, there was an uptick in depreciation expenses, following strategic investments in facility renovations and advanced medical equipment. These capital expenditures (CAPEX) were executed to enhance support more complex and advanced treatments.
Administrative expenses were 226.64 million Baht, an increase of 12.90 million Baht or 6.0%. The main reasons were the increase in the allowance for doubtful accounts downward due to debt collection from government debtors and staff expenses. Additionally, selling and marketing expenses increased, driven by extensive promotional activities for the "Aikchol Health Fair" and billboard rentals and multi-channel media advertising.
Earnings before interest tax depreciation and amortization (EBITDA) was 280.41 in million Baht, an increase of 38.45 in million Baht or 15.9%. Its EBITDA margin stood at 15.2%, against 13.4% of 2024.
Finance Cost
Since the company has adopted TFRS 16 Leases, the accretion of the interest in lease on payments is reflected in finance costs of 0.19 million Baht.
Income Tax
In year 2025, the company’s corporate income tax equaled 36.70 million Baht, an increase of 6.05 million Baht or 19.7%, which represented expenses as a function of profits.
Annual Net Profit
In the year 2025, the company’s net profit was 153.74 million Baht, an increase of 26.73 million Baht or 21.0% from last year. The net profit per share was Baht 1.03 compared to Baht 0.85 in 2024.
Total Comprehensive Income
In the year 2025, comprehensive income was 126.54 million Baht, an increase of 16.06 million Baht or 14.5% over the previous year. The main reasons were the increase in net profit of 26.73 in million Baht, the loss on investment at fair value of Bangkok Dusit Medical Services Plc included tax by 13.33 in million Baht and the increase of income tax relating to components of other comprehensive income that will not be reclassified to profit or loss by 2.67 in million Baht.
Asset Management Ability
Financial Position
Statement of financial position (Unit: Million Baht) | 2025 | 2024 | Change |
Total current assets | 1,645.46 | 1,517.73 | 8.4% |
Total non-current assets | 884.85 | 939.65 | -5.8% |
Total assets | 2,530.31 | 2,457.38 | 3.0% |
Total current liabilities | 279.51 | 275.50 | 1.5% |
Total non-current liabilities | 96.34 | 89.68 | 7.4% |
Total liabilities | 375.85 | 365.18 | 2.9% |
Total Shareholders’ equity | 2,154.46 | 2,092.20 | 3.0% |
Total liabilities and shareholders’ equity | 2,530.31 | 2,457.38 | 3.0% |
Assets
Key components relating to significant changes in assets and asset quality as of December 31, 2025, were detailed below:
- Cash and cash equivalents were 229.81in million Baht, a decrease by 18.94million Baht year-on-year. This was mainly due to the company using cash to invest in mutual funds.
- The account receivable in net trade was 104.05million Baht, an increase of 11.02million Baht from the previous year. This represented the current account receivables average of 20 days of debt collection period. However, these debtors were considered high-grade account receivables, such as government agencies, insurance companies, life assurance companies, and corporate contracts to receive medical services at the hospital. The company has reviewed its allowance for doubtful accounts and bad debts in line with the defined financial reporting standard on a quarterly basis.
Trade and other current receivables | ||||
Trade receivables | 2025 (Baht) | Percentage | 2024 (Baht) | Percentage |
Within credit terms | 58,149,101 | 55.9% | 52,492,331 | 56.4% |
Overdue: | ||||
Less than 3 months | 35,961,790 | 34.6% | 30,078,774 | 32.3% |
3 – 6 months | 906,706 | 0.9% | 1,955,803 | 2.1% |
6 – 12 months | 455,595 | 0.4% | 537,564 | 0.6% |
Over12months | 3,116,549 | 3.0% | 6,703,499 | 7.2% |
Total trade receivables | 98,589,741 | 94.7% | 91,767,971 | 98.6% |
Less allowance for doubtful accounts | -3,341,493 | -3.2% | -6,899,573 | -7.4% |
Net trade receivables | 95,248,248 | 91.5% | 84,868,398 | 91.2% |
Other current receivables | ||||
Prepaid expense | 2,398,591 | 2.3% | 2,180,650 | 2.3% |
Other accrued income | 4,740,946 | 4.6% | 4,474,334 | 4.8% |
Others | 1,665,370 | 1.6% | 1,509,635 | 1.6% |
Other current receivables | 8,804,907 | 8.5% | 8,164,619 | 8.8% |
Total Trade and other current receivables | 104,053,155 | 100.0% | 93,033,017 | 100.0% |
- Inventory was 49.61 in million Baht, an increase of 0.55 in million Baht due tothe number of service recipients, especially in-patients, has decreased during the end of the year due to the inpatient ward's renovation. The company considered the entire inventories of high quality – that is, constantly circulated goods with an average turnaround of 13 days. Therefore, the company decided not to book an allowance for deteriorated or expired inventory.
- Other current financial assets were 1,158.20 in million Baht,an increase of 130.88 in million Baht from the previous year. This was mainly due to the company using cash to invest in mutual funds.
- Property, plant, and equipment totaled 724.85 in million Baht nets, a decrease of 31.31 in million Baht from last year. During the year, the company continued its capital expenditure (CAPEX) program, focusing on advanced medical technology to enhance our clinical capabilities in treating complex medical conditions. Additionally, significant facility renovations were made to the inpatient wards to elevate patient experience and service standards.
- Right-use-of-assets was 9.97 in million Baht, an increase of 7.50 in million Baht from the previous year. This was mainly due to equipment rental.
- Intangible assets stood at 19.80 in million Baht, an increase of 3.01 in million Baht from the previous year. This growth was primarily driven by the ongoing investment in a new operating system, currently recognized under "computer software under development.
Liabilities and Sources of Funds
Suitability of Capital Structure
The financial structure of the company remained robust, respectively. As of December 31, 2025, and 2024, the debt-to-equity ratios were 0.17 and 0.17, respectively. It firmly maintained a strict management policy and control over its financial structure, keeping financial ratios and liquidity appropriate.
Liabilities
The company was completely free of short-term and long-term loans. Most liabilities were from account payables with timely payment. As of December 31, 2025, total liabilities showed at 375.85 in million Baht, an increase of 10.67 in million Baht. The increase in liabilities was primarily driven by payables for fixed assets, resulting from investments in facility renovations and the procurement of advanced medical equipment to support increasingly complex medical treatments.
Equity
As of December 31, 2025, and 2024, total equity stood at 2,154.46 in million Baht and 2,092.20 in million Baht, respectively. Despite the decrease in the value of Bangkok Dusit Medical Services Public Company Limited's equity instruments, the company was able to generate net profit in 2025 and maintain a continuous increase in retained earnings.
Liquidity and Capital Adequacy
Cash Flow
Statement of Cash Flows (Unit: Million Baht) | 2025 | 2024 | Change |
Net cash provided by operating activities | 205.40 | 188.75 | 8.8% |
Net cash used in investing activities | (156.54) | (52.73) | 196.8% |
Net cash used in financing activities | (67.80) | (97.99) | -30.8% |
Net increase (decrease) in cash and cash equivalents | (18.94) | 38.02 | -149.8% |
Cash and cash equivalents at beginning of the year | 248.75 | 210.73 | 18.0% |
Cash and cash equivalents at end of the year | 229.81 | 248.75 | -7.6% |
- The company’s net cash provided by operating activities was 205.40 in million Baht, compared to 188.75 in million Baht from last year. This was mainly due to net profit increasing by 26.73 million Baht, adjusting with increased in expected credit losses of 10.97 in million Baht and a decrease in accrued expenses of 20.56 million Baht.
- The company’s net cash used in investing activities was 156.54 in million Baht, compared to 52.73 in million Baht from last year. This was mainly due to the company investing in medical equipment, renovated facilities, and public financial instruments.
- The company’s net cash used in financing activities was 67.80 in million Baht, compared to 97.99 in million Baht from last year. The primary factor was the Board of Directors' resolution to approve an annual dividend payment align with the net profit for the period.
Key Ratios
In 2025 and 2024, Aikchol maintained current ratios of 5.84 and 5.51, respectively, whereas the quick ratios were 5.67 and 5.33, respectively. Considering all these ratios, it was found that Aikchol’s key current ratios remained strong, demonstrating its high competency in short-term financial obligation payment.
Liability Obligations and Off-Balance Sheet Liability Management
As of December 31, 2025, Aikchol engaged in bank guarantee obligation with a certain commercial bank. It leveraged its fixed deposit to guarantee the use of electricity provided by the Provincial electricity authority with total amount of 1.32 in million Baht.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
Key Factors Affecting Future Performance and Financial Status
The private healthcare sector continues to exhibit an upward growth trajectory, driven by the escalating demand for high-quality medical services and the transition toward the era of precision medicine. This growth is further underpinned by significant structural shifts, most notably the transition into a super-aged society, alongside the persistent pressure of rising operational costs fueled by medical inflation.
Despite the nation's constrained economic expansion, the industry maintains its momentum through key growth drivers. These include the recovery of specific regional segments within the Medical Tourism market and the strategic evolution toward smart hospitals. These supportive factors present a landscape of both strategic opportunities and operational challenges, which directly influence the company’s business performance as detailed below:
1. Transition towards a super-aged society
Thailand is undergoing a rapid demographic shift into a super-aged society. This structural change significantly drives the incidence of non-communicable diseases (NCDs)—such as cancer, cardiovascular diseases, and hypertension—as well as age-related degenerative conditions. The increasing patient volume in this segment poses a challenge to the healthcare system, necessitating advanced medical equipment for complex treatments, long-term care, and rehabilitation, which translates into higher long-term economic costs.
Recognizing this trend, the company views it as a strategic opportunity. The company prepared multidisciplinary teams of specialized physicians to cater to geriatric complications and Long-term Care. Furthermore, maintaining full-time specialists helps reduce referral costs to external facilities and strengthens the hospital's long-term institutional credibility.
2. Restructuring of insurance systems and welfare benefits
As medical inflation continues to rise, life insurance providers are shifting their payment models from lumpsum packages to co-payment or managed care frameworks. This shift has increased price sensitivity among patients, leading to more rigorous price comparisons. Additionally, the emergence of premium clinics at government hospitals during off-hours provides more alternatives for healthcare consumers.
While the company assesses the current impact from insurance cost-control measures and public sector premium services as limited, we remain committed to elevating our clinical quality to international standards. We are refining the patient journey to enhance satisfaction, expanding our specialized medical capabilities, and investing in advanced medical technology and facility upgrades. Furthermore, we are actively forging domestic and international strategic alliances with insurance companies and corporate partners to broaden our customer base and reinforce our integrated medical service ecosystem.
3. Competitive landscape in the private hospital sector
Competition is intensifying, particularly in the Eastern Economic Corridor (EEC) and industrial zones, due to the opening of new hospitals targeting Social Security Scheme members, middle-income class patients, and expatriates. This growth is catalyzed by major infrastructure developments, such as U-Tapao airport and the high-speed rail project. The proliferation of private hospitals and specialized medical centers has heightened competition for service quality, medical personnel, and pricing, potentially increasing the company’s marketing and human resource costs.
In response, the Company focuses on developing centers of excellence, such as advanced trauma centers and specialized NCD centers staffed by multidisciplinary experts. We are also transitioning towards a smart hospital model by implementing new operating systems to enhance patient flow and reduce congestion. This digital transformation allows us to increase our service capacity without the immediate need for bed capacity expansion.
4. Shortage of Medical and Nursing Personnel
Our strategic goal to treat complex diseases requires a higher density of specialized physicians. However, the industry faces a systemic shortage of medical personnel, as the supply is largely dependent on public sector production. This creates a highly competitive environment for talent retention, leading to continuous upward pressure on operating costs due to salary adjustments, cost-of-living allowances, and benefit enhancements.
To ensure sustainable growth, the company has implemented a competitive and standardized compensation structure aligned with regional peers. We emphasize a fair and transparent performance management system and provide continuous professional development opportunities to enhance workforce efficiency and retention.
Amidst these evolving factors, the company remains dedicated to clinical excellence and the expansion of specialized medical centers for complex care. We continue to invest in facility improvements, process optimization, and human capital development. These initiatives are integrated with our sustainable development framework, emphasizing environmental, social, and governance (ESG) principles, to deliver standardized care and a superior experience for both our patients and healthcare professionals.

